Clinical Trial Update: Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of elagolix in pre-menopausal women with heavy uterine bleeding and uterine fibroids has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Uterine Bleeding
• Uterine Fibroids

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Heavy Uterine Bleeding, Uterine Fibroids | Phase 2 | Status: COMPLETED | Results posted: 2020-07-15